Skip to main content

ORIGINAL RESEARCH article

Front. Trop. Dis.
Sec. Antimicrobial Resistance
Volume 6 - 2025 | doi: 10.3389/fitd.2025.1497199
This article is part of the Research Topic Antimicrobial Resistance Response Perspectives in Africa View all articles

Antimicrobial Use in a Paediatric Hospital in Kenya: A Point Prevalence Survey to Inform Antimicrobial Stewardship

Provisionally accepted
Joseph Mbuthia Joseph Mbuthia 1*Nkatha Gitonga Nkatha Gitonga 2Winnie Akoth Winnie Akoth 1*Susan Mutua Susan Mutua 1*Ndinda Kusu Ndinda Kusu 2*Tamara Hafner Tamara Hafner 3*Mohan P Joshi Mohan P Joshi 3*Martha Embrey Martha Embrey 4*
  • 1 Gertrude's Children's Hospital, Nairobi, Kenya
  • 2 USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health, Nairobi, Kenya
  • 3 USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health, Arlington, VA, United States
  • 4 Global Health Systems Innovation, Management Sciences for Health, Arlington, VA, United States

The final, formatted version of the article will be published soon.

    A baseline point prevalence survey (PPS) was conducted at Gertrude's Children's Hospital (GCH), a private paediatric hospital in Kenya, to assess antimicrobial use (AMU) patterns, adherence to antimicrobial stewardship (AMS) protocols, and compliance with treatment guidelines. The survey aimed to provide insights into antimicrobial prescribing practices in a paediatric setting and address a critical gap in data from private healthcare facilities in Kenya. Methods: The PPS included all inpatients as of 13 May 2022, excluding those discharged on that date, day cases, and those prescribed topical antimicrobials. Data were collected using a tool adapted from the WHO's PPS standardized methodology, focusing on antimicrobial prescribing trends, compliance with GCH guidelines, and adherence to WHO's Access, Watch, and Reserve categorization. Results: The results showed that 61% of inpatients were on antimicrobials, with systemic antibacterials (J01) being the most prescribed, particularly third-generation cephalosporins, penicillin combinations, and imidazole derivatives. Ceftriaxone was the most commonly used antimicrobial, and the average number of antimicrobials prescribed per patient was 1.2. Prescribing practices showed a high use of Watch category antibiotics (51%) and a predominant use of the intravenous (IV) route (74%). Discussion: Only 50% of prescriptions complied with guidelines and microbiological findings; we identified significant areas for improvement, including the need for structured reviews of antimicrobial prescriptions, better alignment with AMS objectives, and enhanced training on treatment guidelines, diagnostic stewardship, and infection prevention and control. Conclusion: The survey concludes that the PPS provides valuable data to inform AMS interventions at GCH, recommending the development of policies for IV-to-oral switch criteria, enhancement of the health management system, establishment of antimicrobial ward rounds, and improved education on laboratory result interpretation and appropriate sample collection.

    Keywords: antimicrobial use (AMU), point prevalence survey (PPS), Antimicrobial stewardship (AMS), Antimicrobial resistance (AMR), Paediatric hospital, Private healthcare, antibiotic

    Received: 16 Sep 2024; Accepted: 30 Jan 2025.

    Copyright: © 2025 Mbuthia, Gitonga, Akoth, Mutua, Kusu, Hafner, Joshi and Embrey. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Joseph Mbuthia, Gertrude's Children's Hospital, Nairobi, Kenya
    Winnie Akoth, Gertrude's Children's Hospital, Nairobi, Kenya
    Susan Mutua, Gertrude's Children's Hospital, Nairobi, Kenya
    Ndinda Kusu, USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health, Nairobi, Kenya
    Tamara Hafner, USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health, Arlington, VA, United States
    Mohan P Joshi, USAID Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program, Management Sciences for Health, Arlington, VA, United States
    Martha Embrey, Global Health Systems Innovation, Management Sciences for Health, Arlington, VA, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.